-
Mashup Score: 0Home - 3 day(s) ago
Tuesday, June 4 8:00 – 9:00 PM ET 5:00 – 6:00 PM PT PRESENTERS Jessica Steen, OD, FAAO NOVA Southeastern Fort Lauderdale, Florida Karl G. Stonecipher, MD University of North Carolina Greensboro, NC MIEBO ® (perfluorohexyloctane ophthalmic solution) is indicated fo r the treatment of the signs and symptoms of dry eye disease. MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO Instruct patients
Source: na.eventscloud.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 7Managing Cross-linking Complications - 5 day(s) ago
By Andrew Beers, Associate Editor W hether a patient has keratoconus, ectasia following refractive surgery, or pellucid marginal degeneration, corneal col lagen cross-linking can be used to prevent progression. This treatment is a particularly safe and effective procedure, and rarely do complications arise. However, complications can occur, and some patients may experience negative effects, vision-threatening symptoms as well as continuous progression. Here, experts share their knowledge on what complicatio
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 9Plateau Iris and Angle Closure Management - 7 day(s) ago
E arly identification and treatment of primary angle closure suspects are crucial steps to help lowe r patients’ risk of developing glaucoma. The anatomical nature of their narrow angles will influence how they can be managed and how they respond, particularly if the patient has a plateau iris configuration. We spoke with several glaucoma specialists who offered advice on the clinical definitions and confirmation of narrow angles and plateau iris, treatment options and what to expect in long-term monitorin
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 4Managing Cross-linking Complications - 10 day(s) ago
By Andrew Beers, Associate Editor W hether a patient has keratoconus, ectasia following refractive surgery, or pellucid marginal degeneration, corneal col lagen cross-linking can be used to prevent progression. This treatment is a particularly safe and effective procedure, and rarely do complications arise. However, complications can occur, and some patients may experience negative effects, vision-threatening symptoms as well as continuous progression. Here, experts share their knowledge on what complicatio
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Home - 10 day(s) ago
Tuesday, June 4 8:00 – 9:00 PM ET 5:00 – 6:00 PM PT PRESENTERS Jessica Steen, OD, FAAO NOVA Southeastern Fort Lauderdale, Florida Karl G. Stonecipher, MD University of North Carolina Greensboro, NC MIEBO ® (perfluorohexyloctane ophthalmic solution) is indicated fo r the treatment of the signs and symptoms of dry eye disease. MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO Instruct patients
Source: na.eventscloud.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 6Managing Irregular Astigmatism - 10 day(s) ago
By Christine Yue Leonard, Senior Associate Editor O ne of the more frustrating refractive challenges for both surgeons and patients, corneal irregular astigmatism can arise from a variety of factors, leading to unpredictable visual ou tcomes. The irregular curvature of the cornea not only affects visual clarity but also increases higher-order aberrations such as coma and trefoil, resulting in discomfort from glare and halos around light sources. Treatment strategies must be tailored to address the
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1Transplant Techniques in the Pipeline - 12 day(s) ago
By Michelle Stephenson, Contributing Editor I n recent years, endothelial transplant methods have replaced penetrating keratoplasty for the treatment of Fuch s’ endothelial dystrophy, and several new transplant techniques are currently in the pipeline. The hope is that these new techniques will have a global impact. “In the United States, we’ re very fortunate. We have an excellent eye banking system; we don’ t have tissue shortages. The rest of the world is a different story,” says Kathryn Colby, MD,
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5
Review of Ophthalmology highlights current, clinically relevant information on surgical techniques, disease diagnosis and management and new technologies
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 3Review of Ophthalmology Issue for November 2024 - 14 day(s) ago
In addition to benefiting U.S. patients, these new techniques would address the tissue shortage in other countries. An etiology-based approach is key when addressing this complex refractive situation. Experts offer their perspectives on how to approach narrow angles and plateau iris configuration to mitigate glaucoma risk. Although rare, patients may experience issues following treatment for keratoconus and other corneal conditions. An expert look at risk factors, diagnosis and which treatment methods
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet-
The November issue is out now! In it, surgeons discuss how to manage corneal irregular astigmatism, plateau iris and angle-closure and CXL complications. Plus, a review of the endothelial transplant pipeline. Read now at https://t.co/cHa9ZH3cB9 #ophthalmology #ophthalmologist https://t.co/uwCysMfzfv
-
-
Mashup Score: 0Home - 17 day(s) ago
Tuesday, June 4 8:00 – 9:00 PM ET 5:00 – 6:00 PM PT PRESENTERS Jessica Steen, OD, FAAO NOVA Southeastern Fort Lauderdale, Florida Karl G. Stonecipher, MD University of North Carolina Greensboro, NC MIEBO ® (perfluorohexyloctane ophthalmic solution) is indicated fo r the treatment of the signs and symptoms of dry eye disease. MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO Instruct patients
Source: na.eventscloud.comCategories: General Medicine News, OphthalmologyTweet
#PaidPartnership Join Drs. Stonecipher and Steen for an Educational Webinar on Dry Eye Disease. Registration: https://t.co/CJdzHUErHL #dryeye #eyecare #ophthalmology #optometry https://t.co/3FINnzMfLs